Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Preface.

Falanga A, Brenner B, Rickles FR.

Thromb Res. 2018 Apr;164 Suppl 1:S1-S2. doi: 10.1016/j.thromres.2018.01.051. No abstract available.

PMID:
29703464
2.

The International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) at the Peak of Adolescence - 15 Years and Counting.

Rickles FR, Brenner B, Falanga A.

Thromb Res. 2016 Apr;140 Suppl 1:S99-102. doi: 10.1016/S0049-3848(16)30107-4. Review. No abstract available.

PMID:
27067988
3.

Preface.

Falanga A, Brenner B, Rickles FR.

Thromb Res. 2016 Apr;140 Suppl 1:ix-x. doi: 10.1016/S0049-3848(16)30089-5. No abstract available.

PMID:
27067960
4.

Global public awareness of venous thromboembolism: comment.

Aggarwal A, Rickles FR.

J Thromb Haemost. 2016 May;14(5):1110-1. doi: 10.1111/jth.13214. Epub 2016 Mar 3. No abstract available.

5.

Deep vein thrombosis (DVT) and pulmonary embolism (PE): awareness and prophylaxis practices reported by patients with cancer.

Aggarwal A, Fullam L, Brownstein AP, Maynard GA, Ansell J, Varga EA, Friedman RJ, Rickles FR.

Cancer Invest. 2015;33(9):405-10. doi: 10.3109/07357907.2015.1048871. Epub 2015 Jul 16.

PMID:
26181096
6.

7th international conference on thrombosis and hemostasis issues in cancer. Preface.

Falanga A, Brenner B, Rickles FR.

Thromb Res. 2014 May;133 Suppl 2:ix. doi: 10.1016/S0049-3848(14)50031-X. No abstract available.

PMID:
24862125
7.

Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.

Zwicker JI, Rojan A, Campigotto F, Rehman N, Funches R, Connolly G, Webster J, Aggarwal A, Mobarek D, Faselis C, Neuberg D, Rickles FR, Wun T, Streiff MB, Khorana AA.

J Clin Oncol. 2014 Jun 10;32(17):1792-6. doi: 10.1200/JCO.2013.53.5336. Epub 2014 May 5.

8.

Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study.

Kleinjan A, Di Nisio M, Beyer-Westendorf J, Camporese G, Cosmi B, Ghirarduzzi A, Kamphuisen PW, Otten HM, Porreca E, Aggarwal A, Brodmann M, Guglielmi MD, Iotti M, Kaasjager K, Kamvissi V, Lerede T, Marschang P, Meijer K, Palareti G, Rickles FR, Righini M, Rutjes AW, Tonello C, Verhamme P, Werth S, van Wissen S, Büller HR.

Ann Intern Med. 2014 Apr 1;160(7):451-7. doi: 10.7326/M13-2056.

PMID:
24687068
9.

Capture of lipopolysaccharide (endotoxin) by the blood clot: a comparative study.

Armstrong MT, Rickles FR, Armstrong PB.

PLoS One. 2013 Nov 25;8(11):e80192. doi: 10.1371/journal.pone.0080192. eCollection 2013.

10.

A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism.

Kleinjan A, Aggarwal A, Van de Geer A, Faselis C, Büller HR, Di Nisio M, Rickles FR, Kamphuisen PW.

Thromb Haemost. 2013 Nov;110(5):959-65. doi: 10.1160/TH13-05-0414. Epub 2013 Aug 15.

PMID:
23945725
11.

Aspirin insensitive thrombophilia: transcript profiling of blood identifies platelet abnormalities and HLA restriction.

Fallahi P, Katz R, Toma I, Li R, Reiner J, VanHouten K, Carpio L, Marshall L, Lian Y, Bupp S, Fu SW, Rickles F, Leitenberg D, Lai Y, Weksler BB, Rebling F, Yang Z, McCaffrey TA.

Gene. 2013 May 15;520(2):131-8. doi: 10.1016/j.gene.2013.02.032. Epub 2013 Feb 27.

12.

The infrequent removal of retrievable IVC filters.

El-Amm J, Mobarek DA, Furmark L, Aggarwal A, Faselis C, Rickles FR.

Thromb Res. 2013 Mar;131(3):277-8. doi: 10.1016/j.thromres.2012.12.011. Epub 2013 Jan 22. No abstract available.

PMID:
23351663
13.

6th International Conference on Thrombosis and Hemostasis Issues in Cancer. Preface.

Falanga A, Brenner B, Rickles FR.

Thromb Res. 2012 Apr;129 Suppl 1:ix. doi: 10.1016/S0049-3848(12)70006-3. No abstract available.

PMID:
22682115
14.

Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism.

Parpia S, Julian JA, Thabane L, Lee AY, Rickles FR, Levine MN.

Contemp Clin Trials. 2011 Nov;32(6):829-33. doi: 10.1016/j.cct.2011.07.005. Epub 2011 Jul 18.

PMID:
21777700
15.

Evidence for enhanced tissue factor expression in age-related macular degeneration.

Cho Y, Cao X, Shen D, Tuo J, Parver LM, Rickles FR, Chan CC.

Lab Invest. 2011 Apr;91(4):519-26. doi: 10.1038/labinvest.2010.184. Epub 2010 Nov 1.

16.

Proceedings of the Fifth International Conference on Thrombosis and Hemostasis Issues in Cancer, held in Stresa, Italy, April 23-25, 2010. Preface.

Falanga A, Brenner B, Rickles FR.

Thromb Res. 2010 Apr;125 Suppl 2:ix. doi: 10.1016/S0049-3848(10)70002-5. No abstract available.

PMID:
20434018
17.

Asymptomatic factor VII deficiency: gene analysis and structure-function relationships.

Kirkel D, Lin TW, Fu SW, Dlott JS, Sahud MA, McCaffrey T, Rickles FR.

Blood Coagul Fibrinolysis. 2010 Jan;21(1):91-4. doi: 10.1097/MBC.0b013e328331e708.

PMID:
20040857
18.

Activation of clotting factors in cancer.

Rickles FR, Falanga A.

Cancer Treat Res. 2009;148:31-41. doi: 10.1007/978-0-387-79962-9_3. Review. No abstract available.

PMID:
19377917
19.

Thrombosis associated with angiogenesis inhibitors.

Elice F, Rodeghiero F, Falanga A, Rickles FR.

Best Pract Res Clin Haematol. 2009 Mar;22(1):115-28. doi: 10.1016/j.beha.2009.01.001. Review.

PMID:
19285278
20.

Cancer and thrombosis in women - molecular mechanisms.

Rickles FR.

Thromb Res. 2009;123 Suppl 2:S16-20. doi: 10.1016/S0049-3848(09)70004-0.

PMID:
19217469
21.

Hemostatic complications of angiogenesis inhibitors in cancer patients.

Elice F, Jacoub J, Rickles FR, Falanga A, Rodeghiero F.

Am J Hematol. 2008 Nov;83(11):862-70. doi: 10.1002/ajh.21277. Review.

22.

Cancer and thrombosis is a sticky business.

Rickles FR.

Blood. 2008 Oct 1;112(7):2594-5. doi: 10.1182/blood-2008-07-165647. No abstract available.

PMID:
18809764
23.

Hypercoagulability and tissue factor gene upregulation in hematologic malignancies.

Falanga A, Barbui T, Rickles FR.

Semin Thromb Hemost. 2008 Mar;34(2):204-10. doi: 10.1055/s-2008-1079262. Review.

PMID:
18645927
24.

Tissue factor and cancer.

Rickles FR, Brenner B.

Semin Thromb Hemost. 2008 Mar;34(2):143-5. doi: 10.1055/s-2008-1079253. No abstract available.

PMID:
18645918
25.

Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.

Falanga A, Rickles FR.

Hematology Am Soc Hematol Educ Program. 2007:165-71.

PMID:
18024625
26.

Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?

Rickles FR, Falanga A, Montesinos P, Sanz MA, Brenner B, Barbui T.

Thromb Res. 2007;120 Suppl 2:S99-106. Erratum in: Thromb Res. 2008;123(1):187-90.

PMID:
18023721
27.

Is tissue factor the 'original sin' of clotting, or is it factor VII?

Rickles FR.

J Thromb Haemost. 2007 Jul;5(7):1401-2. No abstract available.

28.

Enhancing participation in clinical research: keys to obtaining informed consent.

Green D, Rickles FR.

J Support Oncol. 2007 Jan;5(1):48-50. Review. No abstract available.

PMID:
17265787
29.

Mechanisms of cancer-induced thrombosis in cancer.

Rickles FR.

Pathophysiol Haemost Thromb. 2006;35(1-2):103-10. Review.

PMID:
16855354
30.

If heparanase is the answer, what is the question?

Rickles FR.

J Thromb Haemost. 2006 Mar;4(3):557-9. No abstract available.

31.

The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS).

Matchar DB, Jacobson AK, Edson RG, Lavori PW, Ansell JE, Ezekowitz MD, Rickles F, Fiore L, Boardman K, Phibbs C, Fihn SD, Vertrees JE, Dolor R.

J Thromb Thrombolysis. 2005 Jun;19(3):163-72.

PMID:
16082603
32.

Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.

Rickles FR, Marder VJ.

J Thromb Haemost. 2005 May;3(5):842-3. No abstract available.

33.

Thrombolytic (fibrinolytic) drugs and progress in treating cardiovascular disease.

Rickles FR.

FASEB J. 2005 Apr;19(6):671. No abstract available.

PMID:
15791008
34.

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.

Lee AY, Rickles FR, Julian JA, Gent M, Baker RI, Bowden C, Kakkar AK, Prins M, Levine MN.

J Clin Oncol. 2005 Apr 1;23(10):2123-9. Epub 2005 Feb 7.

PMID:
15699480
35.

Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom.

Tallman MS, Brenner B, Serna Jde L, Dombret H, Falanga A, Kwaan HC, Liebman H, Raffoux E, Rickles FR.

Leuk Res. 2005 Mar;29(3):347-51.

PMID:
15661272
36.

Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.

Tallman MS, Lefèbvre P, Baine RM, Shoji M, Cohen I, Green D, Kwaan HC, Paietta E, Rickles FR.

J Thromb Haemost. 2004 Aug;2(8):1341-50.

37.

Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents.

Adams BK, Ferstl EM, Davis MC, Herold M, Kurtkaya S, Camalier RF, Hollingshead MG, Kaur G, Sausville EA, Rickles FR, Snyder JP, Liotta DC, Shoji M.

Bioorg Med Chem. 2004 Jul 15;12(14):3871-83.

PMID:
15210154
38.

Tissue factor and fibrin in tumor angiogenesis.

Fernandez PM, Patierno SR, Rickles FR.

Semin Thromb Hemost. 2004 Feb;30(1):31-44. Review.

PMID:
15034796
39.

Tissue factor, thrombin, and cancer.

Rickles FR, Patierno S, Fernandez PM.

Chest. 2003 Sep;124(3 Suppl):58S-68S. Review.

PMID:
12970125
40.

Targeting the endothelium in cancer--the importance of the interaction of hemostatic mechanisms and the vascular wall for tumor growth and angiogenesis.

Rickles FR, Patierno SR, Fernandez PM.

Pathophysiol Haemost Thromb. 2003;33 Suppl 1:1-4. No abstract available.

PMID:
12954987
41.

Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.

Falanga A, Rickles FR.

Best Pract Res Clin Haematol. 2003 Sep;16(3):463-82. Review.

PMID:
12935963
42.

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.

Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators.

N Engl J Med. 2003 Jul 10;349(2):146-53.

43.

Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin.

Fried MW, Peter J, Hoots K, Gaglio PJ, Talbut D, Davis PC, Key NS, White GC, Lindblad L, Rickles FR, Abshire TC.

Hepatology. 2002 Oct;36(4 Pt 1):967-72.

PMID:
12297845
44.

Tissue factor and angiogenesis in cancer.

Fernandez PM, Rickles FR.

Curr Opin Hematol. 2002 Sep;9(5):401-6. Review.

PMID:
12172458
45.

Relationship of blood clotting and tumor angiogenesis.

Rickles FR.

Haemostasis. 2001;31 Suppl 1:16-20. No abstract available.

PMID:
11990466
46.

Epidemiology of thrombosis in cancer.

Rickles FR, Levine MN.

Acta Haematol. 2001;106(1-2):6-12.

PMID:
11549771
47.

Molecular basis for the relationship between thrombosis and cancer.

Rickles FR, Falanga A.

Thromb Res. 2001 Jun 15;102(6):V215-24. Review.

PMID:
11516455
49.

Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring.

Ezekowitz MD, James KE, Radford MJ, Rickles FR, Redmond N.

J Cardiovasc Pharmacol Ther. 1999 Jan;4(1):3-8.

PMID:
10684518
50.

Supplemental Content

Loading ...
Support Center